CTMX logo
CTMX

CytomX Therapeutics Inc

Biotechnology

CytomX Therapeutics Inc (CTMX) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.12
EPS actual
Revenue est.
$4.8M
Revenue actual